A polyclonal antibody to human recombinant angiogenin was prepared in rabbits using a Pam 3 CysSerGly conjugate. The antibody was then used to develop the first highly sensitive enzyme-labelled immunometric assay for this vascularisation inducing and tumour associated protein. The assay was suitable for quantification of angiogenin in body fluids between 2.5 and 0.05 g/l. The mean intra-assay imprecision was 6.0% and the inter-assay imprecision 7.9%. Angiogenin in human plasma was found to lie in the range of 0.38 to 0.11 mg/1 with a mean of 0.25 + 0.07 mg/1.
Introduction
Angiogenin is a single chain Af r 14100 protein, first isolated and characterised from a HT-29 human adenocarcinoma cell line (1) . It has been shown to be an inducer of vascular growth. The protein has 35% identity with pancreatic ribonuclease (2) and has been shown to inhibit protein synthesis in vitro (3) . Saxena et al. described angiogenin as a cytotoxic, t-RNAspecific ribonuclease iii the RNase A superfamily (4) . Angiogenic and ribonucleolytic activities are blocked by a tight-binding placental ribonuclease inhibitor (5) . Recently, it was shown that angiogenin supports endothelial and fibroblast cell adhesion (6) . Shapiro el al. isolated angiogenin from human plasma (7) . Its mRNA was detected predominantly in the adult liver, but was also detectable at a low level in other tissues (8) and cells (9) . Detailed information on the presence of the protein in body fluids and tissues is not available due to the lack of a sensitive and easily performed assay.
Here we report the production of a polyclonal antibody, which was then used to develop the first sensitive immunometric assay for the determination of this protein. The method will facilitate an understanding of the role of angiogenin in physiological and pathophysiological processes.
Materials and Methods

Materials
Nunc Immuno plates II were obtained from Nunc (Roskilde, Denmark). Horseradish peroxidase 1 ) was obtained from Boehringer Mannheim (Mannheim, Germany) and 2,2'-azino-bis(3-ethyl-benzthiazoline-6-sulphonic acid (ABTS) from Sigma (Deisenhofen, Germany). Human recombinant angiogenin was kindly donated by Behringwerke, Marburg. Blood samples were supplied by Prof. Kleesiek, Herzzentrum Bad Oeynhausen-(Bad Oeynhausen, Germany). 
Conjugation of horseradish peroxidase to the IgG
The polyclonal IgG was reacted with horseradish peroxidase by a method described by Tijssen & Kurstak (13) .
Sensitivity and precision
The standard curve for angiogenin was used to optimize reaction conditions ( fig. 1 
Recovery experiment
Recovery of angiogenin in plasma. The antigen standards, diluted in 0.2 mol/1 phosphate-buffered saline/Tween/bovine serum albumin, were added to the prediluted plasma samples. This mixture was serially diluted in 8 steps and analysed by immunoenzymometric assay. Means from those dilutions giving response of A^nm between 0.2 and 1.5 were selected.
Plasma analysis
Plasma samples of healthy donors were stored at -75 °C until required. A prediction of 1 :100 was chosen for measurement. All tests, performed twice on two different days, resulted in deviations not above the inter-assay coefficients given in table 1.
Results
Production of antibodies
The Pam 3 CysSerOly/angiogenin conjugate in combination with Pam 3 CysSerLys 4 as adjuvant was very effective in the production of antibodies in rabbits. Remarkably high litres remained constant for over one year, and more than 0.5 g of antibody could be gained from one rabbit. Tab. 1. Precision of the sandwich ELISA for the determination of angiogenin in phosphatase-buffered saline/Tween/ bovine serum albumin. In order to ascertain the precision, profile concentrations were determined from the absorbance values using prediluted plasma samples at different concentrations. These concentrations were used to calculate the standard deviations (SD) and coefficients of variation (CV).
Concentration
Intra-assay imprecision (n = 8)
Inter-assay imprecision (n = 12) SD CV SD CV donors, it was confirmed that the results always showed the same proportional response to dilution in donor plasma and the reference material. Thus, it is acceptable to record results from the reference curve (15) . The mean analytical recovery tested for concentrations between 2.5 and 0.16 μg/l was 99%, which was very good for this method.
Determination of angiogenin concentrations in plasma
In order to determine normal ranges for angiogenin 65 plasma samples from healthy donors were analysed. The measurement was unaffected by repeated freezing of the sample.
Angiogenin in the plasma was found in the range of 0.38 to 0.11 mg/1 with a mean of 0.25 ± 0.07 mg/1 ( fig. 3 ). There was no significant difference in the concentrations determined in the plasma of female or male donors.
Discussion
In this paper, we present the first highly sensitive assay for angiogenin. The antibodies prepared by the use of a novel adjuvant were of good affinity and litre. The sensitivity of the assay was about 300 times higher than that of a previously reported assay, which was based on the binding of angiogenin to a placental ribonuclease inhibitor and measurement of its ribonucleolytic activity (16) . The ELISA procedure described here is much easier and faster to perform. Angiogenin has 35% identity with human pancreatic ribonuclease (2) . Since this value is not very high, cross-reactivity with this ribunuclease is not to be expected.
Shapiro et al. (7) reported the isolation of angiogenin from human plasma with a yield of 60-150 μ §/1. From our studies, there is no doubt that they must have lost some protein during their purification procedure. In another paper Bicknell et al. (17) reported a value of 400 μg/l in human plasma without giving the assay procedure or number of samples. Our ELISA procedure represents the first highly reliable routine determination of angiogenin in plasma samples and other body fluids.
Angiogenin is a constituent of normal plasma from healthy donors (7) . Its participation as a regulatory component in vascular growth and blood vessel formation is still unresolved, since vascular growth is rapid in the developing rat fetus though angiogenin mRNA levels are low or undetectable (8) . Angiogenin may, however, be involved in such processes in adults or during wound healing, since the chick chorioallantoic assay responds to as little as 35 fmol per egg. New blood vessels are formed in the rabbit cornea following application of 3.5 pmol angiogenin (2) . Angiogenin may also be a serum tRNase and it may hydrolyse tRNA-like molecules outside cells, and perhaps also inside cells when such molecules gain entry during certain physiological or pathological processes. A cytotoxic effect was reported for angiogenin when injected into Xenopus oocytes, and this was related to its cellular tRNase activity (4) . Angiogenin activates phospholipase C, elicits a rapid incorporation of fatty acids into cholesterol esters in vascular smooth muscle cells (18) , and depresses the concentration of cAMP in aortic smooth muscle cells by a mechanism that is sensitive to pertussis toxin (19) .
Since angiogenin is a tumour-derived protein with in vivo angiogenic activity, first isolated from an established human adenocarcinoma cell line (1), it may also serve as a tumour marker for certain malignant carcinomas. The ELISA established here will provide an important tool for assaying the angiogenin concentrations of plasma, tissues and tissue fluids, in order to correlate its concentration with pathological events.
